Fig. 6
From: Y-90 SIRT: evaluation of TCP variation across dosimetric models
Change in predicted tumor dose and normal liver dose when prescribing to 15% NTCP, instead of a 120 Gy absorbed dose to the infused volume via the standard model, is charted against the liver targeted volume fraction